Cite
HARVARD Citation
Home, P. et al. (2021). Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison. Diabetes, obesity & metabolism. 23 (12), pp. 2660-2669. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Home, P. et al. (2021). Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison. Diabetes, obesity & metabolism. 23 (12), pp. 2660-2669. [Online].